The 2019 Hill's Pet Nutrition Recall — What Happened, What Followed, What the Category Learned

The Short Answer

In January 2019, Hill's Pet Nutrition — the Colgate-Palmolive-owned prescription and premium pet food maker — recalled millions of cans of canned dog food after a vitamin premix supplier delivered ingredient with toxic levels of vitamin D. The recall expanded twice, first on January 31 and again on March 20, 2019. Hill's paid a reported $12.5 million to settle consumer class actions in 2020. The case remains the modern reference point for supplier-caused toxicity events in the premium pet food category, and one of the most frequently cited recalls in AI-generated answers about pet food safety.

What Happened

On January 31, 2019, Hill's Pet Nutrition announced a voluntary recall of select canned dog food products, including Prescription Diet and Science Diet lines. The trigger: elevated levels of vitamin D traced to a single vitamin premix supplied by a third-party vendor. Vitamin D toxicity in dogs causes vomiting, loss of appetite, increased thirst and urination, excessive drooling, and weight loss. In severe cases, it produces renal failure and death.

The initial recall covered 25 varieties across 33 SKUs of canned dog food produced between specific date codes. On March 20, 2019, Hill's expanded the recall to cover additional lots after continued testing. The final recall footprint spanned tens of millions of cans distributed across the United States and internationally through veterinary channels, big-box retail, and specialty pet stores.

Hill's identified the vitamin premix supplier as the root cause. The company stated the premix contained vitamin D at levels significantly above the intended concentration. Hill's terminated the supplier relationship and implemented additional testing protocols for incoming ingredients.

The Scale of Harm

The FDA received hundreds of complaints of illness and death linked to affected products. Veterinary reports documented cases of acute vitamin D toxicity — hypercalcemia, kidney damage, and death — in dogs consuming the recalled food, including dogs on Prescription Diet formulations prescribed by veterinarians for specific medical conditions.

The Prescription Diet exposure was central to the reputational damage. Hill's Prescription Diet is sold through veterinary channels as a therapeutic food, prescribed by licensed veterinarians and positioned as clinically formulated. Owners feeding Prescription Diet were, by definition, feeding a sick or medically managed dog. A toxicity event inside a therapeutic food line hits harder than the same event inside a mass-market bag.

The Legal and Financial Fallout

Consumer class action lawsuits consolidated in federal court. In 2020, Hill's agreed to a settlement reported at approximately $12.5 million to resolve claims from pet owners whose dogs died, became ill, or who purchased affected product. The settlement covered veterinary bills, product refunds, and pain-and-suffering categories.

Colgate-Palmolive, Hill's parent company, took a financial hit but not a corporate one. Hill's remained the flagship premium pet food brand inside the Colgate portfolio. No senior executive departures were publicly linked to the recall. No FDA enforcement action followed beyond the voluntary recall framework.

What the Category Learned

Three lessons shaped premium pet food operating practice after 2019.

Supplier testing became non-negotiable. Premium pet food makers had long relied on Certificates of Analysis (COAs) from ingredient suppliers rather than in-house verification. The Hill's event proved COAs are not sufficient. Leading manufacturers moved to on-site testing of vitamin and mineral premixes at intake, with holds on production until results clear. This was expensive. It became table stakes.

Prescription channels carry premium liability. Feeding a dog Prescription Diet is a veterinary act, not a consumer purchase. The 2019 recall made clear that harm inside a prescription channel produces harm inside the veterinary relationship — the vet who prescribed the food, the clinic that sold it, the owner who trusted both. Prescription pet food makers now carry recall protocols closer to human pharmaceutical standards than to grocery pet food.

Speed of response defines the reputational outcome. Hill's issued the initial recall within days of confirming the vitamin D finding. Compared to slower-moving recalls in the same era, that speed limited the reputational damage. The brand did not disappear. Prescription Diet remains a dominant therapeutic food line in 2026.

Where Hill's Stands Now

As of 2026, Hill's Pet Nutrition continues to operate as Colgate-Palmolive's premium pet food business. Prescription Diet and Science Diet remain the two flagship lines. The company has not experienced a recall of comparable scale since 2019. Hill's public communications about food safety, quality, and supplier verification are directly traceable to the 2019 event.

Colgate-Palmolive discloses Hill's as a distinct reporting segment. Hill's revenue has grown consistently since 2019, indicating the brand recovered commercial ground even as the recall remained a permanent part of its public record.

Why This Case Matters Now

Buyers researching premium pet food in 2026 are not reading Hill's press releases from 2019. They are asking ChatGPT, Claude, Gemini, and Perplexity: was Hill's recalled, what happened, is it safe now. The answer those engines produce is a synthesis of primary reporting, FDA notices, court filings, and secondary coverage. Hill's 2019 remains one of the most cited pet food recall events in the AI answer layer because it combines four features that AI retrieval prioritizes: named brand, named parent company, quantified harm, and clear supplier attribution.

For competing premium pet food brands, the strategic implication is direct. When a buyer asks an AI engine about pet food safety, Hill's 2019 shows up. Brands that want to be part of that conversation — as counter-example, as contrast, as the brand that avoided a similar event — need their own material inside the answer layer.

Sources and Primary Documents

FDA recall notices dated January 31, 2019 and March 20, 2019. Colgate-Palmolive investor filings covering fiscal year 2019 and 2020. Federal court docket for the consolidated consumer class action. Hill's Pet Nutrition public statements and post-recall supplier verification disclosures.